EinterzE.M., BatesM.E.Caring for neonatal tetanus patients in a rural primary care setting in Nigeria: a review of 237 cases. J Trop Pediatr1991; 37: 179–181.
2.
OkuonghaeH.O., AiredeA.I.Neonatal tetanus: incidence and improved outcome with diazepam. Dev Med Child Neurol1992; 34: 448–453.
3.
TrujilloM.H., CastilloA., EspanaJ., ManzoA., ZerpaR.Impact of intensive care management on the prognosis of tetanus. Chest1987; 92: 63–65.
4.
RubidgeC.J., WesleyA.G.Infectious diseases: Tetanus. In: Coovadia HM, Loening WEK, eds. Paediatrics and Child Health. A handbook for health professionals in the third world. Cape Town: Oxford University Press, 1988; 8: 171–173.
5.
BenedictC.R., KerrJ.H.Assessment of sympathetic overactivity in tetanus. Br Med J1977; 2: 806.
6.
AlferyD.D., RauscherL.A.Tetanus: a review. Crit Care Med1979; 7: 176–181.
7.
BehrmanR.E., VaughanV.C.Disturbances of rate and rhythm of the heart. In: BehrmanR.E., VaughanV.C., NelsonW.E., eds. Nelson's Textbook of Pediatrics.London: WB Saunders Company, 1983; 1171–1174.
8.
GarsonA.Arrhythmias in pediatric patients. Med Clin North Am1984; 31: 1175–1195.
9.
DiMarcoJ.P., SellersT.D., LermanB.B.Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol1985; 6: 417–424.
10.
BuchananN., SmitL., CaneR.D., De AndradeM.Sympathetic overactivity in tetanus: fatality associated with propanolol. Br Med J1978; 222 July: 254–255.
11.
WesleyA.G., HariparsadD., PatherM., RockeD.A.Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia1983; 38: 243–249.
12.
AbramsJ., AllenJ., AndersonS.Efficacy and safety of esmolol vs propanolol in the treatment of supraventricular tachyarrythmias: a multicentre double-blind clinical trial. Am Heart J1985; 110: 913–922.